DE69622855D1 - Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten - Google Patents

Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten

Info

Publication number
DE69622855D1
DE69622855D1 DE69622855T DE69622855T DE69622855D1 DE 69622855 D1 DE69622855 D1 DE 69622855D1 DE 69622855 T DE69622855 T DE 69622855T DE 69622855 T DE69622855 T DE 69622855T DE 69622855 D1 DE69622855 D1 DE 69622855D1
Authority
DE
Germany
Prior art keywords
arginine
lactobacillus plantarum
pharmaceutical compositions
contain lactobacillus
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69622855T
Other languages
English (en)
Other versions
DE69622855T2 (de
Inventor
Diya Adawi
Bengt Jeppson
Goeran Molin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Probi AB
Original Assignee
Probi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi AB filed Critical Probi AB
Application granted granted Critical
Publication of DE69622855D1 publication Critical patent/DE69622855D1/de
Publication of DE69622855T2 publication Critical patent/DE69622855T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
DE69622855T 1995-05-09 1996-05-08 Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten Expired - Fee Related DE69622855T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501719A SE9501719D0 (sv) 1995-05-09 1995-05-09 Pharmaceutical composition
PCT/SE1996/000603 WO1996035440A1 (en) 1995-05-09 1996-05-08 Pharmaceutical composition comprising lactobacillus plantarum and arginine

Publications (2)

Publication Number Publication Date
DE69622855D1 true DE69622855D1 (de) 2002-09-12
DE69622855T2 DE69622855T2 (de) 2003-04-10

Family

ID=20398250

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69622855T Expired - Fee Related DE69622855T2 (de) 1995-05-09 1996-05-08 Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
DE0825869T Pending DE825869T1 (de) 1995-05-09 1996-05-08 Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE0825869T Pending DE825869T1 (de) 1995-05-09 1996-05-08 Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten

Country Status (16)

Country Link
EP (1) EP0825869B1 (de)
JP (1) JP4058560B2 (de)
KR (1) KR19990008403A (de)
CN (1) CN1152678C (de)
AT (1) ATE221783T1 (de)
AU (1) AU704886B2 (de)
BR (1) BR9608284A (de)
CA (1) CA2220498A1 (de)
DE (2) DE69622855T2 (de)
EE (1) EE03597B1 (de)
ES (1) ES2112818T3 (de)
GR (1) GR980300028T1 (de)
NO (1) NO317668B1 (de)
PL (1) PL184603B1 (de)
SE (1) SE9501719D0 (de)
WO (1) WO1996035440A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
CN1183916C (zh) 2000-03-24 2005-01-12 雀巢制品公司 乳酸细菌在制备用于治疗和预防腹膜炎的载体中的用途
KR100585391B1 (ko) * 2002-01-24 2006-06-01 주식회사 프로바이오닉 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 프란타럼 Probio-38 및 이를 함유하는 생균활성제
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2005094848A1 (ja) * 2004-03-31 2005-10-13 Calpis Co., Ltd. 肝障害予防又は抑制剤及び肝障害予防又は抑制用機能性食品
KR100592717B1 (ko) * 2004-11-20 2006-06-26 주식회사 알엔에이 간 손상 보호 및 예방에 유용한 활성을 갖는 조성물
CN1322111C (zh) * 2004-12-17 2007-06-20 上海交大昂立股份有限公司 一种植物乳杆菌
CN100337653C (zh) * 2004-12-21 2007-09-19 上海交大昂立股份有限公司 一种含有植物乳杆菌的组合物
AU2006296837B2 (en) 2005-09-28 2012-12-13 Nordic Rebalance A/S Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
KR101075558B1 (ko) * 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101075557B1 (ko) 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
WO2010064434A1 (ja) * 2008-12-03 2010-06-10 国立大学法人広島大学 肝機能障害予防剤
KR101255050B1 (ko) 2009-07-14 2013-04-16 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101486999B1 (ko) * 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
TWI463986B (zh) * 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
JP7136807B2 (ja) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
WO2023104887A1 (en) * 2021-12-09 2023-06-15 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota

Also Published As

Publication number Publication date
WO1996035440A1 (en) 1996-11-14
KR19990008403A (ko) 1999-01-25
NO975136L (no) 1997-11-07
NO317668B1 (no) 2004-11-29
JP4058560B2 (ja) 2008-03-12
ES2112818T3 (es) 2003-02-16
CN1152678C (zh) 2004-06-09
GR980300028T1 (en) 1998-04-30
EE9700269A (et) 1998-04-15
CN1190346A (zh) 1998-08-12
DE69622855T2 (de) 2003-04-10
NO975136D0 (no) 1997-11-07
EP0825869A1 (de) 1998-03-04
PL323320A1 (en) 1998-03-16
AU5784696A (en) 1996-11-29
DE825869T1 (de) 1998-07-16
EP0825869B1 (de) 2002-08-07
AU704886B2 (en) 1999-05-06
CA2220498A1 (en) 1996-11-14
EE03597B1 (et) 2002-02-15
JPH11504936A (ja) 1999-05-11
BR9608284A (pt) 1999-06-08
SE9501719D0 (sv) 1995-05-09
ES2112818T1 (es) 1998-04-16
PL184603B1 (pl) 2002-11-29
ATE221783T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
DE69622855T2 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
BR0206689A (pt) Combinação de probióticos, e, uso desta
GR3026758T3 (en) Lactobacillus strains of human origin, their compositions and uses thereof
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
DE69839993D1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
HUP9901707A2 (hu) Gasztrointesztinális rendellenességek megelőzésére és kezelésére szolgáló gyógyászati, és diétás készítmények
BG101118A (en) Therapeutical compounds
ES2074698T3 (es) Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
HUP0104410A2 (hu) Ateroszklerózis megelőzésére és/vagy kezelésére szolgáló gyógyszerkészítmények
BR0111506A (pt) Complexos de droga macromoleculares e composições contendo os mesmos
HK1075654A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
WO1999003509A3 (de) Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie
DE60012521D1 (de) BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD
RS20050603A (en) New combinations and new application of pharmaceutically active compounds
BR9506507A (pt) Forma galênica de derivados de 5-nitro-imadazol composiçoes farmacêuticas microgrânulos gastro-protegidos de derivados de 5-nitro-imidazol e produto da combinaçao
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee